Signifor LAR 20 MG
Ended Awarded
- Contract number
- 36C24525N0967
- Awardee
-
Recordati Rare Diseases Inc. UEI LL38YHW3Y9P4
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,242
Award facts
- Contract value 100% obligated
- $11,241.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
Recordati Rare Diseases Inc. received a $11,241.96 firm fixed-price delivery order from Veterans Integrated Service Network 5 (VISN 5) for Signifor LAR 20 mg, a specialized pharmaceutical treatment for rare endocrine disorders such as Cushing's disease and acromegaly. The award, issued on September 5, 2025, with an ultimate completion date of September 9, 2025, represents a small but critical procurement to support veteran healthcare services in the Bartlett, Tennessee area. This delivery order carries no set-aside designation and falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
This procurement is executed under a larger indefinite-delivery vehicle structure, specifically a single-award Blanket Purchase Agreement valued at $3.16 million running from July 2021 through July 2026 with the Veterans Integrated Service Network 12, which streamlines the VA's access to Recordati's specialized rare disease pharmaceutical portfolio. Recordati Rare Diseases Inc., a foreign-owned pharmaceutical manufacturer specializing in rare disease treatments, has established itself as a key supplier to the VA through multiple delivery orders and blanket purchase agreements, demonstrating its critical role in providing advanced therapeutic options for complex veteran health conditions.
Quick answers
Who was awarded contract 36C24525N0967?
36C24525N0967 was awarded to Recordati Rare Diseases Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on September 5, 2025.
How much is contract 36C24525N0967 worth?
The government has obligated $11,242 on 36C24525N0967.
Is contract 36C24525N0967 an order under another contract?
Yes. 36C24525N0967 is a delivery order under 36F79721D0141, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0967 competed?
The extent of competition for 36C24525N0967 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award